|
1
|
Kobata A and Amano J: Altered
glycosylation of proteins produced by malignant cells and
application for the diagnosis and immunotherapy of tumours. Immunol
Cell Biol. 83:429–439. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benson V, Grobarova V, Richter J and
Fiserova A: Glycosylation regulates NK cell-mediated effector
function through PI3K pathway. Int Immunol. 22:167–177. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lau E, Feng Y, Claps G, Fukuda MN, Perlina
A, Donn D, Jilaveanu L, Kluger H, Freeze HH and Ronai ZA: The
transcription factor ATF2 promotes melanoma metastasis by
suppressing protein fucosylation. Sci Signal. 8:ra1242015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pinho SS and Reis CA: Glycosylation in
cancer: Mechanisms and clinical implications. Nat Rev Cancer.
15:540–555. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cipolla L, La Ferla B and Gregori M:
Combinatorial approaches to iminosugars as glycosidase and
glycosyltransferase inhibitors. Comb Chem High Throughput Screen.
9:571–582. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abbott KL, Nairn AV, Hall EM, Horton MB,
McDonald JF, Moremen KW, Dinulescu DM and Pierce M: Focused
glycomic analysis of the N-linked glycan biosynthetic pathway in
ovarian cancer. Proteomics. 8:3210–3220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang X, Wang N, Pei C, Sun L, Sun R, Chen
J and Liu Y: Glycan-related gene expression signatures in human
metastatic hepatocellular carcinoma cells. Exp Ther Med. 3:415–422.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song Y, Aglipay JA, Bernstein JD, Goswami
S and Stanley P: The bisecting GlcNAc on N-glycans inhibits growth
factor signaling and retards mammary tumor progression. Cancer Res.
70:3361–3371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chakraborty AK, Sousa Jde F, Chakraborty
D, Funasaka Y, Bhattacharya M, Chatterjee A and Pawelek J: GnT-V
expression and metastatic phenotypes in macrophage-melanoma fusion
hybrids is down-regulated by 5-Aza-dC: Evidence for methylation
sensitive, extragenic regulation of GnT-V transcription. Gene.
374:166–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lau KS and Dennis JW: N-Glycans in cancer
progression. Glycobiology. 18:750–760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yoshinaga A, Kajiya N, Oishi K, Kamada Y,
Ikeda A, Chigwechokha PK, Kibe T, Kishida M, Kishida S and Komatsu
M: NEU3 inhibitory effect of naringin suppresses cancer cell growth
by attenuation of EGFR signaling through GM3 ganglioside
accumulation. Eur J Pharmacol. 782:21–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galindo-Murillo R, Sandoval-Salinas ME and
Barroso-Flores J: In Silico design of monomolecular drug carriers
for the tyrosine kinase inhibitor drug imatinib based on calix- and
thiacalix [n]arene host molecules: A DFT and molecular dynamics
study. J Chem Theory Comput. 10:825–834. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cherenok S, Vovk A, Muravyova I, Shivanyuk
A, Kukhar V, Lipkowski J and Kalchenko V: Calix[4]arene
alpha-aminophosphonic acids: Asymmetric synthesis and
enantioselective inhibition of an alkaline phosphatase. Org Lett.
8:549–552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou H, Wang DA, Baldini L, Ennis E, Jain
R, Carie A, Sebti SM and Hamilton AD: Structure-activity studies on
a library of potent calix[4]arene-based PDGF antagonists that
inhibit PDGF-stimulated PDGFR tyrosine phosphorylation. Org Biomol
Chem. 4:2376–2386. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geraci C, Consoli GM, Galante E, Bousquet
E, Pappalardo M and Spadaro A: Calix[4]arene decorated with four Tn
antigen glycomimetic units and P3CS immunoadjuvant: Synthesis,
characterization and anticancer immunological evaluation. Bioconjug
Chem. 19:751–758. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Esfand R and Tomalia DA: Poly(amidoamine)
(PAMAM) dendrimers: From biomimicry to drug delivery and biomedical
applications. Drug Discov Today. 6:427–436. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schleicher ED and Weigert C: Role of the
hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int
Suppl. 77:S13–S18. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hinderlich S, Berger M, Schwarzkopf M,
Effertz K and Reutter W: Molecular cloning and characterization of
murine and human N-acetylglucosamine kinase. Eur J Biochem.
267:3301–3308. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Phatnani HP and Greenleaf AL:
Phosphorylation and functions of the RNA polymerase II CTD. Genes
Dev. 20:2922–2936. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gorboulev V, Schürmann A, Vallon V, Kipp
H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard
R, et al: Na+-D-glucose cotransporter SGLT1 is pivotal
for intestinal glucose absorption and glucose-dependent incretin
secretion. Diabetes. 61:187–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferguson KM, Berger MB, Mendrola JM, Cho
HS, Leahy DJ and Lemmon MA: EGF activates its receptor by removing
interactions that autoinhibit ectodomain dimerization. Mol Cell.
11:507–517. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang XQ, Sun P, O'Gorman M, Tai T and
Paller AS: Epidermal growth factor receptor glycosylation is
required for ganglioside GM3 binding and GM3-mediated suppression
(correction of suppresion) of activation. Glycobiology. 11:515–522.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grobárová V, Benson V, Rozbeský D, Novák P
and Cerný J: Re-evaluation of the involvement of NK cells and
C-type lectin-like NK receptors in modulation of immune responses
by multivalent GlcNAc-terminated oligosaccharides. Immunol Lett.
156:110–117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krenek K, Kuldová M, Hulíková K, Stibor I,
Lhoták P, Dudic M, Budka J, Pelantová H, Bezouska K, Fiserová A and
Kren V: N-acetyl-D-glucosamine substituted calix[4]arenes as
stimulators of NK cell-mediated antitumor immune response.
Carbohydr Res. 342:1781–1792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vannucci L, Fiserová A, Sadalapure K,
Lindhorst TK, Kuldová M, Rossmann P, Horváth O, Kren V, Krist P,
Bezouska K, et al: Effects of N-acetyl-glucosamine-coated
glycodendrimers as biological modulators in the B16F10 melanoma
model in vivo. Int J Oncol. 23:285–296. 2003.PubMed/NCBI
|
|
27
|
Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH,
Fidler IJ and Hung MC: Survival of cancer cells is maintained by
EGFR independent of its kinase activity. Cancer Cell. 13:385–393.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han Y, San-Marina S, Yang L, Khoury H and
Minden MD: The zinc finger domain of Wilms' tumor 1 suppressor gene
(WT1) behaves as a dominant negative, leading to abrogation of WT1
oncogenic potential in breast cancer cells. Breast Cancer Res.
9:R432007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ullmannová V, Stöckbauer P, Hradcová M,
Soucek J and Haskovec C: Relationship between cyclin D1 and
p21Waf1/Cip1 during differentiation of human myeloid
leukemia cell lines. Leuk Res. 27:1115–1123. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Klatt AR, Paul-Klausch B, Klinger G, Kühn
G, Renno JH, Banerjee M, Malchau G and Wielckens K: A critical role
for collagen II in cartilage matrix degradation: Collagen II
induces pro-inflammatory cytokines and MMPs in primary human
chondrocytes. J Orthop Res. 27:65–70. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Den Berg DJ, Sharma AK, Bruno E and
Hoffman R: Role of members of the Wnt gene family in human
hematopoiesis. Blood. 92:3189–3202. 1998.PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Besancenot R, Roos-Weil D, Tonetti C,
Abdelouahab H, Lacout C, Pasquier F, Willekens C, Rameau P, Lecluse
Y, Micol JB, et al: JAK2 and MPL protein levels determine
TPO-induced megakaryocyte proliferation vs differentiation. Blood.
124:2104–2115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moliterno AR, Hankins WD and Spivak JL:
Impaired expression of the thrombopoietin receptor by platelets
from patients with polycythemia vera. N Engl J Med. 338:572–580.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moliterno AR, Williams DM, Rogers O and
Spivak JL: Molecular mimicry in the chronic myeloproliferative
disorders: Reciprocity between quantitative JAK2 V617F and Mpl
expression. Blood. 108:3913–3915. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marhäll A, Kazi JU and Rönnstrand L: The
Src family kinase LCK cooperates with oncogenic FLT3/ITD in
cellular transformation. Sci Rep. 7:137342017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rousset D, Agnès F, Lachaume P, André C
and Galibert F: Molecular evolution of the genes encoding receptor
tyrosine kinase with immunoglobulinlike domains. J Mol Evol.
41:421–429. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Higgins DF, Ewart LM, Masterson E, Tennant
S, Grebnev G, Prunotto M, Pomposiello S, Conde-Knape K, Martin FM
and Godson C: BMP7-induced-Pten inhibits Akt and prevents renal
fibrosis. Biochim Biophys Acta. 1863:3095–3104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Anticevic D, Jelic M and Vukicevic S:
Treatment of a congenital pseudarthrosis of the tibia by osteogenic
protein-1 (bone morphogenetic protein-7): A case report. J Pediatr
Orthop B. 15:220–221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Honda Y, Knutsen R, Strong DD, Sampath TK,
Baylink DJ and Mohan S: Osteogenic protein-1 stimulates mRNA levels
of BMP-6 and decreases mRNA levels of BMP-2 and −4 in human
osteosarcoma cells. Calcif Tissue Int. 60:297–301. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao Y, Scott A, Zhang P, Hao Y, Feng X,
Somasundaram S, Khalil AM, Willis J and Wang Z: Regulation of
paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts
colon tumorigenesis. Oncotarget. 8:48782–48793. 2017.PubMed/NCBI
|
|
42
|
Bourgonje AM, Verrijp K, Schepens JT,
Navis AC, Piepers JA, Palmen CB, van den Eijnden M, Hooft van
Huijsduijnen R, Wesseling P, Leenders WP and Hendriks WJ:
Comprehensive protein tyrosine phosphatase mRNA profiling
identifies new regulators in the progression of glioma. Acta
Neuropathol Commun. 4:962016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yeo L, Adlard N, Biehl M, Juarez M,
Smallie T, Snow M, Buckley CD, Raza K, Filer A and Scheel-Toellner
D: Expression of chemokines CXCL4 and CXCL7 by synovial macrophages
defines an early stage of rheumatoid arthritis. Ann Rheum Dis.
75:763–771. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sullam PM, Frank U, Yeaman MR, Täuber MG,
Bayer AS and Chambers HF: Effect of thrombocytopenia on the early
course of streptococcal endocarditis. J Infect Dis. 168:910–914.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Aziz H, Zaas A and Ginsburg GS: Peripheral
blood gene expression profiling for cardiovascular disease
assessment. Genomic Med. 1:105–112. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
De Plaen IG, Han XB, Liu X, Hsueh W, Ghosh
S and May MJ: Lipopolysaccharide induces CXCL2/macrophage
inflammatory protein-2 gene expression in enterocytes via NF-kappaB
activation: Independence from endogenous TNF-alpha and
platelet-activating factor. Immunology. 118:153–163. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sarvaiya PJ, Guo D, Ulasov I, Gabikian P
and Lesniak MS: Chemokines in tumor progression and metastasis.
Oncotarget. 4:2171–2185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang HL, Anatelli F, Zhai QJ, Adley B,
Chuang ST and Yang XJ: Glypican-3 as a useful diagnostic marker
that distinguishes hepatocellular carcinoma from benign
hepatocellular mass lesions. Arch Pathol Lab Med. 132:1723–1728.
2008.PubMed/NCBI
|
|
49
|
Tretiakova M, Zynger DL, Luan C, Andeen
NK, Finn LS, Kocherginsky M, Teh BT and Yang XJ: Glypican 3
overexpression in primary and metastatic Wilms tumors. Virchows
Arch. 466:67–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mitra N, Banda K, Altheide TK, Schaffer L,
Johnson-Pais TL, Beuten J, Leach RJ, Angata T, Varki N and Varki A:
SIGLEC12, a human-specific segregating (pseudo)gene, encodes a
signaling molecule expressed in prostate carcinomas. J Biol Chem.
286:23003–23011. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Marballi K, Quinones MP, Jimenez F,
Escamilla MA, Raventós H, Soto-Bernardini MC, Ahuja SS and
Walss-Bass C: In vivo and in vitro genetic evidence of involvement
of neuregulin 1 in immune system dysregulation. J Mol Med.
88:1133–1141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Girkin J, Hatchwell L, Foster P, Johnston
SL, Bartlett N, Collison A and Mattes J: CCL7 and IRF-7 mediate
hallmark inflammatory and IFN responses following rhinovirus 1b
infection. J Immunol. 194:4924–4930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Than NG, Romero R, Xu Y, Erez O, Xu Z,
Bhatti G, Leavitt R, Chung TH, El-Azzamy H, LaJeunesse C, et al:
Evolutionary origins of the placental expression of chromosome 19
cluster galectins and their complex dysregulation in preeclampsia.
Placenta. 35:855–865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Waghray M, Yalamanchili M, Dziubinski M,
Zeinali M, Erkkinen M, Yang H, Schradle KA, Urs S, Pasca Di
Magliano M, Welling TH, et al: GM-CSF mediates
mesenchymal-epithelial cross-talk in pancreatic cancer. Cancer
Discov. 6:886–899. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Akpa MM, Iglesias DM, Chu LL, Cybulsky M,
Bravi C and Goodyer PR: Wilms tumor suppressor, WT1, suppresses
epigenetic silencing of the β-catenin gene. J Biol Chem.
290:2279–2288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Riboldi E, Daniele R, Parola C, Inforzato
A, Arnold PL, Bosisio D, Fremont DH, Bastone A, Colonna M and
Sozzani S: Human C-type lectin domain family 4, member C
(CLEC4C/BDCA-2/CD303) is a receptor for
asialo-galactosyl-oligosaccharides. J Biol Chem. 286:35329–35333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shi Q, Liu H, Han P, Li C, Wang Y, Wu W,
Zhu D, Amos CI, Fang S, Lee JE, et al: Genetic variants in WNT2B
and BTRC predict melanoma survival. J Invest Dermatol.
137:1749–1756. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lin SY, Li K, Stewart GS and Elledge SJ:
Human Claspin works with BRCA1 to both positively and negatively
regulate cell proliferation. Proc Natl Acad Sci USA. 101:pp.
6484–6489. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Focarelli ML, Soza S, Mannini L, Paulis M,
Montecucco A and Musio A: Claspin inhibition leads to fragile site
expression. Genes Chromosomes Cancer. 48:1083–1090. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ohta K, Shigeishi H, Taki M, Nishi H,
Higashikawa K, Takechi M and Kamata N: Regulation of CXCL9/10/11 in
oral keratinocytes and fibroblasts. J Dent Res. 87:1160–1165. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sidhu NS, Schreiber K, Pröpper K, Becker
S, Usón I, Sheldrick GM, Gärtner J, Krätzner R and Steinfeld R:
Structure of sulfamidase provides insight into the molecular
pathology of mucopolysaccharidosis IIIA. Acta Crystallogr D Biol
Crystallogr. 70:1321–1335. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang X, Wan JX, Ke ZP, Wang F, Chai HX
and Liu JQ: TMEM88, CCL14 and CLEC3B as prognostic biomarkers for
prognosis and palindromia of human hepatocellular carcinoma. Tumour
Biol. 39:10104283177089002017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yu H, Gaochao Z, Huaquan W, Limin X,
Lijuan L, Huijuan J, Wei Z, Jinglian T and Zonghong S: GDF11 is
increased in patients with myelodysplastic syndrome. Int J Clin Exp
Pathol. 9:6031–6038. 2016.
|
|
64
|
Safaee M, Ivan ME, Oh MC, Oh T, Sayegh ET,
Kaur G, Sun MZ, Bloch O and Parsa AT: The role of epidermal growth
factor-like module containing mucin-like hormone receptor 2 in
human cancers. Oncol Rev. 8:2422014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Fernández-Vega I, García-Suárez O, García
B, Crespo A, Astudillo A and Quirós LM: Heparan sulfate
proteoglycans undergo differential expression alterations in right
sided colorectal cancer, depending on their metastatic character.
BMC Cancer. 15:7422015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Pelizzaro-Rocha KJ, de Jesus MB,
Ruela-de-Sousa RR, Nakamura CV, Reis FS, de Fátima A and
Ferreira-Halder CV: Calix[6]arene bypasses human pancreatic cancer
aggressiveness: Downregulation of receptor tyrosine kinases and
induction of cell death by reticulum stress and autophagy. Biochim
Biophys Acta. 1833:2856–2865. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Saovapakhiran A, D'Emanuele A, Attwood D
and Penny J: Surface modification of PAMAM dendrimers modulates the
mechanism of cellular internalization. Bioconjug Chem. 20:693–701.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wright EM, Loo DD and Hirayama BA: Biology
of human sodium glucose transporters. Physiol Rev. 91:733–794.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Guo GF, Cai YC, Zhang B, Xu RH, Qiu HJ,
Xia LP, Jiang WQ, Hu PL, Chen XX, Zhou FF, et al: Overexpression of
SGLT1 and EGFR in colorectal cancer showing a correlation with the
prognosis. Med Oncol. 28 Suppl 1:S197–S203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Parimi S, Barnes TJ, Callen DF and
Prestidge CA: Mechanistic insight into cell growth, internalization
and cytotoxicity of PAMAM dendrimers. Biomacromolecules.
11:382–389. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Crocker PR, McMillan SJ and Richards HE:
CD33-related siglecs as potential modulators of inflammatory
responses. Ann N Y Acad Sci. 1253:102–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Virgo P, Denning-Kendall PA,
Erickson-Miller CL, Singha S, Evely R, Hows JM and Freeman SD:
Identification of the CD33-related Siglec receptor, Siglec-5
(CD170), as a useful marker in both normal myelopoiesis and acute
myeloid leukaemias. Br J Haematol. 123:420–430. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hudson SA, Herrmann H, Du J, Cox P, Haddad
el-B, Butler B, Crocker PR, Ackerman SJ, Valent P and Bochner BS:
Developmental, malignancy-related and cross-species analysis of
eosinophil, mast cell and basophil siglec-8 expression. J Clin
Immunol. 31:1045–1053. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Potapenko IO, Haakensen VD, Lüders T,
Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC and
Børresen-Dale AL: Glycan gene expression signatures in normal and
malignant breast tissue; possible role in diagnosis and
progression. Mol Oncol. 4:98–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Guo H, Nagy T and Pierce M:
Post-translational glycoprotein modifications regulate colon cancer
stem cells and colon adenoma progression in Apcmin/+
mice through altered WNT receptor signaling. J Biol Chem.
289:31534–31549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Radisky DC, Levy DD, Littlepage LE, Liu H,
Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et
al: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and
genomic instability. Nature. 436:123–127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ferrari G, Cook BD, Terushkin V, Pintucci
G and Mignatti P: Transforming growth factor-beta 1 (TGF-beta1)
induces angiogenesis through vascular endothelial growth factor
(VEGF)-mediated apoptosis. J Cell Physiol. 219:449–458. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Dings RP, Miller MC, Nesmelova I,
Astorgues-Xerri L, Kumar N, Serova M, Chen X, Raymond E, Hoye TR
and Mayo KH: Antitumor agent calixarene 0118 targets human
galectin-1 as an allosteric inhibitor of carbohydrate binding. J
Med Chem. 55:5121–5129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu WC, Lin YL, Spearman M, Cheng PY,
Butler M and Wu SC: Influenza virus hemagglutinin glycoproteins
with different N-glycan patterns activate dendritic cells in vitro.
J Virol. 90:6085–6096. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Abiola M, Favier M,
Christodoulou-Vafeiadou E, Pichard AL, Martelly I and
Guillet-Deniau I: Activation of Wnt/beta-catenin signaling
increases insulin sensitivity through a reciprocal regulation of
Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One.
4:e85092009. View Article : Google Scholar : PubMed/NCBI
|
